Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Exchange	Industry	Market Cap	Price	1d %	EBITDA	P/E	D/E
ACAD	ACADIA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$2.81B	$17.05	2.03%	-$45.48M	-46.08x	0.74
ACET	ADICET BIO INC	NASDAQ	Biotechnology	$124.87M	$1.52	2.01%	-$133.69M	-0.46x	0.22
ACST	ACASTI PHARMA INC	NASDAQ	Biotechnology	$26.79M	$2.85	2.52%	-$48.89M	-0.56x	0.18
ADMA	ADMA BIOLOGICS INC	NASDAQ	Biotechnology	$1.52B	$6.67	2.30%	$5.12M	-51.31x	1.44
ANAB	ANAPTYSBIO INC	NASDAQ	Biotechnology	$696.38M	$26.02	6.90%	-$161.25M	-4.28x	4.14
AQST	AQUESTIVE THERAPEUTICS INC	NASDAQ	Drug Manufacturers - Specialty & Generic	$246.66M	$3.37	0.15%	$1.18M	-25.88x	-1.54
ARTL	ARTELO BIOSCIENCES INC	NASDAQ	Biotechnology	$4.20M	$1.30	-5.45%	-$9.25M	-0.41x	0.11
AVIR	ATEA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$324.03M	$3.85	4.05%	-$134.52M	-2.36x	0.07
BDTX	BLACK DIAMOND THERAPEUTICS INC	NASDAQ	Biotechnology	$305.14M	$5.90	5.92%	-$82.01M	-3.14x	0.36
ORIC	ORIC PHARMACEUTICALS INC	NASDAQ	Biotechnology	$628.62M	$9.33	5.66%	-$99.67M	-4.76x	0.13
PASG	PASSAGE BIO INC	NASDAQ	Biotechnology	$75.06M	$1.35	4.65%	-$98.34M	-0.73x	0.35
CGON	CG ONCOLOGY INC	NASDAQ	Biotechnology	$2.71B	$40.62	1.07%	-$55.48M	-2.60x	-0.12
CLSD	CLEARSIDE BIOMEDICAL INC	NASDAQ	Biotechnology	$94.90M	$1.27	0.79%	-$32.42M	-2.40x	-3.14
CNTA	CENTESSA PHARMACEUTICALS PLC	NASDAQ	Biotechnology	$950.90M	$9.48	3.49%	-$165.43M	-6.04x	0.53
TNDM	TANDEM DIABETES CARE INC	NASDAQ	Medical Devices	$2.38B	$36.20	-1.34%	-$194.66M	-10.55x	2.04
CRMD	CORMEDIX INC	NASDAQ	Biotechnology	$303.50M	$5.52	5.04%	-$46.23M	-6.07x	0.17
CMPS	COMPASS PATHWAYS PLC	NASDAQ	Medical Care Facilities	$544.65M	$8.48	-1.05%	-$113.21M	-3.66x	0.22
DOMH	DOMINARI HOLDINGS INC	NASDAQ	Biotechnology	$13.75M	$2.32	-2.24%	-$22.44M	-0.53x	0.09
EXAI	EXSCIENTIA PLC	NASDAQ	Biotechnology	$646.11M	$5.14	3.84%	-$192.47M	-3.40x	0.44
FEMY	FEMASYS INC	NASDAQ	Medical Instruments & Supplies	$28.73M	$1.30	2.36%	-$13.17M	-1.40x	0.51
KURA	KURA ONCOLOGY INC	NASDAQ	Biotechnology	$1.54B	$20.28	3.36%	-$150.23M	-9.75x	0.13
LAB	STANDARD BIOTOOLS INC	NASDAQ	Diagnostics & Research	$736.90M	$2.54	2.42%	-$65.66M	-2.70x	-1.08
IMRX	IMMUNEERING CORP	NASDAQ	Biotechnology	$44.80M	$1.53	7.75%	-$52.71M	-0.81x	0.13
IPSC	CENTURY THERAPEUTICS INC	NASDAQ	Biotechnology	$197.05M	$3.04	4.47%	-$122.40M	-1.32x	0.95
LVTX	LAVA THERAPEUTICS NV	NASDAQ	Biotechnology	$78.08M	$2.97	2.77%	-$47.16M	-1.74x	0.99
VRAX	VIRAX BIOLABS GROUP LTD	NASDAQ	Biotechnology	$1.18M	$0.65	3.02%	N/A	-0.22x	0.15
KRON	KRONOS BIO INC	NASDAQ	Biotechnology	$61.90M	$1.03	0.00%	-$107.76M	-0.53x	0.34
TARO	TARO PHARMACEUTICAL INDUSTRIES LTD	NYSE	Drug Manufacturers - Specialty & Generic	$1.59B	$42.39	-0.21%	N/A	34.75x	0.22
LENZ	LENZ THERAPEUTICS INC	NASDAQ	Biotechnology	$131.53M	$15.81	-0.38%	-$117.96M	-1.03x	0.03
LTRN	LANTERN PHARMA INC	NASDAQ	Biotechnology	$57.90M	$5.39	5.69%	-$15.79M	-3.67x	0.07
OGN	ORGANON & CO	NYSE	Drug Manufacturers - General	$4.81B	$18.83	1.18%	$1.44B	4.70x	-173.26
OMGA	OMEGA THERAPEUTICS INC	NASDAQ	Biotechnology	$136.78M	$2.48	11.21%	-$90.66M	-1.38x	2.52
NKTX	NKARTA INC	NASDAQ	Biotechnology	$370.13M	$7.49	12.13%	-$109.41M	-3.12x	0.39
NRIX	NURIX THERAPEUTICS INC	NASDAQ	Biotechnology	$642.89M	$13.08	8.82%	-$130.28M	-4.92x	0.85
TKNO	ALPHA TEKNOVA INC	NASDAQ	Drug Manufacturers - Specialty & Generic	$77.97M	$1.91	7.30%	-$30.45M	-1.65x	0.43
ZNTL	ZENTALIS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$802.56M	$11.31	2.26%	-$291.40M	-2.53x	0.26
MORF	MORPHIC HOLDING INC	NASDAQ	Biotechnology	$1.40B	$27.97	2.57%	-$159.71M	-7.99x	0.03
LGND	LIGAND PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.26B	$71.42	2.19%	N/A	N/A	0.12
SHLT	SHL TELEMEDICINE LTD	NASDAQ	Health Information Services	$76.23M	$4.65	-4.32%	$3.32M	-10.81x	0.50
MGRM	MONOGRAM ORTHOPAEDICS INC	NASDAQ	Medical Devices	$61.69M	$1.95	-5.57%	-$13.33M	-3.20x	0.24
SABS	SAB BIOTHERAPEUTICS INC	NASDAQ	Biotechnology	$37.82M	$4.10	-4.43%	-$38.13M	-0.54x	0.47
SNDX	SYNDAX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.87B	$21.97	3.98%	-$208.40M	-7.37x	0.11
TXMD	THERAPEUTICSMD INC	NASDAQ	Drug Manufacturers - Specialty & Generic	$21.74M	$1.89	0.27%	-$9.40M	-1.92x	0.48
VCEL	VERICEL CORP	NASDAQ	Biotechnology	$2.27B	$47.08	2.64%	$8.93M	-672.57x	0.57
NBTX	NANOBIOTIX SA	NASDAQ	Biotechnology	$282.80M	$6.00	2.74%	-$25.02M	-5.17x	-51.95
PHR	PHREESIA INC	NYSE	Health Information Services	$1.18B	$21.01	1.30%	-$107.36M	-8.37x	0.47
PRGO	PERRIGO CO PLC	NYSE	Drug Manufacturers - Specialty & Generic	$4.46B	$32.90	0.73%	$516.70M	-365.56x	1.27
VRCA	VERRICA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$290.57M	$6.85	-1.65%	-$62.20M	-4.63x	3.13
QLI	QILIAN INTERNATIONAL HOLDING GROUP LTD	NASDAQ	Drug Manufacturers - Specialty & Generic	$23.24M	$0.65	-11.44%	-$6.52M	-2.95x	0.16
VXRT	VAXART INC	NASDAQ	Biotechnology	$121.88M	$0.70	-1.96%	-$73.58M	-1.23x	0.59
XBIT	XBIOTECH INC	NASDAQ	Biotechnology	$248.48M	$8.16	6.39%	-$22.57M	-10.07x	0.04
PCVX	VAXCYTE INC	NASDAQ	Biotechnology	$6.91B	$63.71	5.22%	-$392.10M	-15.39x	0.14
BNTC	BENITEC BIOPHARMA INC	NASDAQ	Biotechnology	$20.48M	$7.90	-6.51%	-$21.44M	-73.15x	0.38
ATHA	ATHIRA PHARMA INC	NASDAQ	Biotechnology	$78.19M	$2.04	3.55%	-$116.49M	-0.66x	0.23
XENE	XENON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$3.21B	$42.49	4.53%	-$179.14M	-15.56x	0.04
PMVP	PMV PHARMACEUTICALS INC	NASDAQ	Biotechnology	$95.68M	$1.86	3.33%	-$68.07M	-1.29x	0.12
PRLD	PRELUDE THERAPEUTICS INC	NASDAQ	Biotechnology	$204.85M	$3.73	-1.06%	-$118.73M	-1.85x	0.17
CBUS	CIBUS INC	NASDAQ	Biotechnology	$412.90M	$17.11	0.35%	-$244.57M	-0.66x	0.70
DYAI	DYADIC INTERNATIONAL INC	NASDAQ	Biotechnology	$42.59M	$1.47	2.80%	-$6.80M	-6.13x	0.40
EQ	EQUILLIUM INC	NASDAQ	Biotechnology	$51.47M	$1.46	-2.01%	-$12.14M	-3.84x	1.24
EKSO	EKSO BIONICS HOLDINGS INC	NASDAQ	Medical Instruments & Supplies	$23.17M	$1.28	2.82%	-$12.30M	-1.31x	1.06
ANNX	ANNEXON INC	NASDAQ	Biotechnology	$427.62M	$4.75	4.40%	-$130.97M	-2.68x	0.19
APDN	APPLIED DNA SCIENCES INC	NASDAQ	Diagnostics & Research	$3.42M	$4.03	0.75%	-$5.89M	-0.37x	1.37
PCSA	PROCESSA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$6.34M	$2.22	1.83%	-$11.04M	-0.26x	0.16
KTTA	PASITHEA THERAPEUTICS CORP	NASDAQ	Biotechnology	$7.21M	$6.92	0.00%	-$15.31M	-0.53x	0.12
LPTX	LEAP THERAPEUTICS INC	NASDAQ	Biotechnology	$83.71M	$3.27	5.48%	-$81.40M	-0.82x	0.21
ABEO	ABEONA THERAPEUTICS INC	NASDAQ	Biotechnology	$106.96M	$3.91	-5.56%	-$50.57M	-1.55x	3.32
GDRX	GOODRX HOLDINGS INC	NASDAQ	Health Information Services	$2.75B	$6.97	-1.83%	$112.93M	-348.50x	1.09
NXTC	NEXTCURE INC	NASDAQ	Biotechnology	$38.23M	$1.37	13.22%	-$58.47M	-0.61x	0.12
STRO	SUTRO BIOPHARMA INC	NASDAQ	Biotechnology	$233.53M	$3.74	10.16%	-$66.98M	-2.10x	2.15
GPCR	STRUCTURE THERAPEUTICS INC	NASDAQ	Biotechnology	$1.83B	$39.32	-0.30%	-$88.46M	-16.18x	0.06
TYRA	TYRA BIOSCIENCES INC	NASDAQ	Biotechnology	$960.61M	$18.29	6.96%	-$68.78M	-11.29x	0.11
NUVB	NUVATION BIO INC	NYSE	Biotechnology	$700.95M	$3.20	7.02%	-$75.65M	-9.14x	0.03
XGN	EXAGEN INC	NASDAQ	Diagnostics & Research	$23.44M	$1.36	-1.81%	-$18.21M	-1.01x	1.51
ORGO	ORGANOGENESIS HOLDINGS INC	NASDAQ	Drug Manufacturers - Specialty & Generic	$331.23M	$2.51	6.81%	$36.03M	62.75x	0.65
VOR	VOR BIOPHARMA INC	NASDAQ	Biotechnology	$120.66M	$1.77	2.91%	-$109.64M	-1.01x	0.31
PTPI	PETROS PHARMACEUTICALS INC	NASDAQ	Drug Manufacturers - Specialty & Generic	$4.52M	$0.66	-2.81%	-$4.21M	-0.10x	1.77
VRNA	VERONA PHARMA PLC	NASDAQ	Biotechnology	$1.23B	$15.22	-1.49%	-$51.16M	-21.14x	0.24
MNOV	MEDICINOVA INC	NASDAQ	Biotechnology	$63.27M	$1.29	0.00%	-$8.35M	-7.59x	0.06
ELYM	ELIEM THERAPEUTICS INC	NASDAQ	Biotechnology	$209.84M	$7.57	6.77%	-$34.71M	-5.82x	0.03
SYRS	SYROS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$143.91M	$5.44	0.74%	-$157.12M	-0.94x	9.09
ALDX	ALDEYRA THERAPEUTICS INC	NASDAQ	Biotechnology	$247.36M	$4.20	6.60%	-$35.21M	-6.56x	0.24
PTIX	PROTAGENIC THERAPEUTICS INC	NASDAQ	Biotechnology	$5.77M	$1.30	-5.59%	-$4.86M	-1.13x	0.18
SLNO	SOLENO THERAPEUTICS INC	NASDAQ	Biotechnology	$1.54B	$47.54	6.45%	-$36.71M	-20.14x	0.15
HSCS	HEART TEST LABORATORIES INC	NASDAQ	Medical Devices	$6.10M	$0.09	1.09%	-$6.00M	-0.19x	0.25
GH	GUARDANT HEALTH INC	NASDAQ	Diagnostics & Research	$2.22B	$18.26	1.44%	-$433.31M	-4.27x	10.26
BCRX	BIOCRYST PHARMACEUTICALS INC	NASDAQ	Biotechnology	$942.11M	$4.57	10.65%	-$116.34M	-3.87x	-2.14
GDTC	CYTOMED THERAPEUTICS LTD	NASDAQ	Biotechnology	$24.70M	$2.14	1.42%	-$2.72M	-7.46x	0.10
QNCX	QUINCE THERAPEUTICS INC	NASDAQ	Biotechnology	$42.91M	$0.99	-7.20%	-$31.26M	-1.18x	0.97
ENTX	ENTERA BIO LTD	NASDAQ	Biotechnology	$70.96M	$2.00	2.04%	-$8.80M	-6.45x	0.13
EPIX	ESSA PHARMA INC	NASDAQ	Biotechnology	$292.86M	$6.62	2.95%	-$25.69M	-11.22x	0.03
DSGN	DESIGN THERAPEUTICS INC	NASDAQ	Biotechnology	$204.51M	$3.62	2.84%	-$66.29M	-3.04x	0.04
WVE	WAVE LIFE SCIENCES LTD	NASDAQ	Biotechnology	$693.35M	$5.67	15.01%	-$48.98M	-10.50x	5.74
AONC	AMERICAN ONCOLOGY NETWORK INC	NASDAQ	Health Information Services	$137.51M	$3.85	0.79%	-$39.93M	-2.83x	-1.88
IPA	IMMUNOPRECISE ANTIBODIES LTD	NASDAQ	Biotechnology	$32.89M	$1.25	-2.34%	-$7.05M	-3.03x	0.58
ABOS	ACUMEN PHARMACEUTICALS INC	NASDAQ	Biotechnology	$195.26M	$3.25	0.93%	-$51.61M	-3.01x	0.16
XWEL	XWELL INC	NASDAQ	Diagnostics & Research	$7.15M	$1.71	-3.93%	-$24.16M	-0.26x	1.39
CDTX	CIDARA THERAPEUTICS INC	NASDAQ	Biotechnology	$53.87M	$11.81	-1.42%	-$21.21M	-2.27x	-9.16
CELC	CELCUITY INC	NASDAQ	Biotechnology	$496.39M	$16.30	3.36%	-$58.31M	-6.06x	0.37
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	NASDAQ	Biotechnology	$78.80M	$1.43	2.88%	-$59.36M	-1.32x	0.25

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	682	+2.73%	+3.18%	-7.19%	-21.03%	7.71x	6.02x	-68.56%	+3.07%	+21.74%	+84.82%	Strong Buy
Diagnostics & Research	66	+0.70%	-0.56%	-6.06%	-2.35%	38.50x	4.18x	-22.82%	+6.39%	+10.99%	+11.35%	Buy
Drug Manufacturers - General	17	+0.52%	+3.18%	-0.94%	+13.75%	151.40x	6.24x	+34.95%	+8.30%	+14.47%	+13.15%	Buy
Drug Manufacturers - Specialty & Generic	90	+0.48%	+3.46%	-1.40%	-6.22%	32.65x	2.12x	+11.34%	+2.71%	+5.06%	+33.93%	Strong Buy
Healthcare Plans	12	-0.30%	-2.39%	-5.75%	-2.55%	18.65x	2.84x	+19.97%	+6.14%	+14.20%	+17.58%	Buy
Health Information Services	61	+0.90%	-0.31%	-7.89%	-25.07%	75.21x	3.28x	+6.22%	+2.03%	+5.22%	+36.70%	Buy
Medical Care Facilities	51	+0.26%	-1.00%	-5.53%	+5.10%	-1.05x	4.40x	-80.36%	+6.53%	+13.61%	+17.61%	Buy
Medical Devices	154	+2.20%	+0.21%	-4.02%	-15.23%	30.19x	3.68x	+10.60%	+5.30%	+7.71%	+21.30%	Buy
Medical Distribution	9	-1.68%	-1.91%	-3.95%	+32.84%	25.61x	124.98x	-7.98%	+3.49%	+19.48%	+8.16%	Buy
Medical Instruments & Supplies	56	+0.51%	+0.32%	-3.15%	-12.42%	55.14x	3.53x	+11.66%	+7.78%	+10.33%	+20.96%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the top healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -5.36% over the past year, overperforming other healthcare stocks by 5 percentage points.

2. Progyny (NASDAQ:PGNY)

Progyny (NASDAQ:PGNY) is the second best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock lose -3.87% over the past year, overperforming other healthcare stocks by 6 percentage points.

Progyny has an average 1 year price target of $47.00, an upside of 45.56% from Progyny's current stock price of $32.29.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Progyny, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the third best healthcare stock with a Zen Score of 65, which is 40 points higher than the healthcare sector average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Inmode has seen its stock lose -54.14% over the past year, underperforming other healthcare stocks by -44 percentage points.

Inmode has an average 1 year price target of $27.00, an upside of 56.61% from Inmode's current stock price of $17.24.

Inmode stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Inmode, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 66.67% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 54 percentage points higher than the healthcare sector average of 2.8%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.27%, which is 8 percentage points higher than the healthcare sector average of 2.8%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.95%, which is 5 percentage points higher than the healthcare sector average of 2.8%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 158.2% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 1.29% in the last day, and up 0.91% over the last week. Cytomx Therapeutics was the among the top gainers in the healthcare sector, gaining 214.72% yesterday.

CytomX Therapeutics shares are trading higher after the company announced that it will report Q1 2024 results and provide an initial CX-904 Phase 1a dose escalation update on May 8, 2024.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -42.17% in the past year. It has underperformed other stocks in the healthcare sector by -32 percentage points.

2. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -54.14% in the past year. It has underperformed other stocks in the healthcare sector by -44 percentage points.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has dropped -5.36% in the past year. It has overperformed other stocks in the healthcare sector by 5 percentage points.

Are healthcare stocks a good buy now?

47.87% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 37.59% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 70.86x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.